Nottingham clinico-pathological response index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer
© 2014 AACR. Purpose: There is a need to identify more sensitive clinicopathologic criteria to assess the response to neoadjuvant chemotherapy (Neo-ACT) and guide subsequent adjuvant therapy. Experimental Design: We performed a clinicopathologic assessment of 426 patients who had completed Neo-ACT f...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
American Association for Cancer Research Inc.
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/27145 |